Literature DB >> 18006458

Transmural temporospatial left ventricular activation during pacing from different sites: potential implications for optimal pacing.

Katherine M Kavanagh1, Israel Belenkie, Henry J Duff.   

Abstract

AIMS: Previous studies showed that right ventricular (RV) endocardial pacing can be deleterious even in individuals with initially normal left ventricular (LV) function. The mechanism(s) by which RV endocardial pacing may cause LV dysfunction is unknown. This study compares the temporospatial LV transmyocardial activation profiles during sinus rhythm with normal His/Purkinje conduction vs. currently utilized and proposed cardiac pacing sites. METHODS AND
RESULTS: Mongrel dogs were instrumented with transmural electrodes that tracked transmyocardial activation sequences at five sites in the LV. Pacing/recording catheters were positioned in the RV apex and on the RV and LV sides of the ventricular septum. An epicardial pacing electrode was also sewn to the mid-lateral LV epicardium. Electrograms were recorded during sinus rhythm and pacing from the RV endocardium, LV septum, LV epicardium and during biventricular pacing. Compared to normal sinus/His/Purkinje rhythm (NSR), RV endocardial pacing significantly (P < 0.05) prolonged transmural activation (NSR endocardium 6.1 +/- 1 ms vs. RV endocardium 23.0 +/- 2.6 ms). The highly ordered temporospatial pattern of transmural activation during sinus rhythm was replaced with dispersion and intermingling of endo-, mid-, and epicardial activation. LV epicardial and biventricular pacing did not correct these abnormalities. Only LV septal pacing achieved the transmural and transseptal activation sequences similar to sinus rhythm.
CONCLUSION: Clinically utilized pacing modalities, including biventricular pacing, cause abnormal transmyocardial activation. LV septal pacing results in transmyocardial activation patterns that closely resemble those seen in sinus rhythm.

Entities:  

Mesh:

Year:  2007        PMID: 18006458     DOI: 10.1093/cvr/cvm036

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  6 in total

1.  Left ventricular systolic dysfunction induced by ventricular ectopy: a novel model for premature ventricular contraction-induced cardiomyopathy.

Authors:  Jose F Huizar; Karoly Kaszala; Jonathan Potfay; Anthony J Minisi; Edward J Lesnefsky; Antonio Abbate; Eleonora Mezzaroma; Qun Chen; Rakesh C Kukreja; Nicholas N Hoke; Leroy R Thacker; Kenneth A Ellenbogen; Mark A Wood
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-05-16

2.  The effect of left ventricular pacing on transmural activation delay in myopathic human hearts.

Authors:  Andreu Porta-Sánchez; Paul Angaran; Stéphane Massé; Krishnakumar Nair; Talha Farid; Karthikeyan Umapathy; John Asta; Sigfus Gizurarson; Kumaraswamy Nanthakumar
Journal:  Europace       Date:  2018-04-01       Impact factor: 5.214

3.  A randomized comparison of defibrillation thresholds in the right ventricular outflow tract versus right ventricular apex.

Authors:  Michael Mollerus; Margaret Lipinski; Thomas Munger
Journal:  J Interv Card Electrophysiol       Date:  2008-05-10       Impact factor: 1.900

4.  Spatial characterization of electrogram morphology from transmural recordings in the intact normal heart.

Authors:  Jim Pouliopoulos; William Chik; Karen Byth; Elizabeth Wallace; Pramesh Kovoor; Aravinda Thiagalingam
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

5.  Acute impact of pacing at different cardiac sites on left ventricular rotation and twist in dogs.

Authors:  Zhi-Wen Zhou; Bu-Chun Zhang; Yi Yu; Kai Guo; Wei Li; Rui Zhang; Peng-Pai Zhang; Yi-Gang Li
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

Review 6.  Optimal site selection and image fusion guidance technology to facilitate cardiac resynchronization therapy.

Authors:  Benjamin J Sieniewicz; Justin Gould; Bradley Porter; Baldeep S Sidhu; Jonathan M Behar; Simon Claridge; Steve Niederer; Christopher A Rinaldi
Journal:  Expert Rev Med Devices       Date:  2018-07-30       Impact factor: 3.166

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.